Biodel Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
39
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
12
- Investments
-
1
Biodel General Information
Description
Developer of endocrine disorders treatments based in Danbury, Connecticut. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules.
Contact Information
Website
www.biodel.comCorporate Office
- 100 Saw Mill Road
- Danbury, CT 06810
- United States
Corporate Office
- 100 Saw Mill Road
- Danbury, CT 06810
- United States
Biodel Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biodel Comparisons
Industry
Financing
Details
Biodel Competitors (63)
One of Biodel’s 63 competitors is 4D pharma, a Corporation company based in Leeds, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 4D pharma | Corporation | Leeds, United Kingdom | ||||
| Vedanta Biosciences | Venture Capital-Backed | Cambridge, MA | ||||
| Voyager Therapeutics | Formerly VC-backed | Lexington, MA | ||||
| WaVe Life Sciences | Formerly VC-backed | Cambridge, MA | ||||
| Maze Therapeutics | Formerly VC-backed | South San Francisco, CA |
Biodel Signals
Biodel Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Biodel Acquisitions (1)
Biodel’s most recent deal was a Reverse Merger with Albireo. The deal was made on 03-Nov-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Albireo | 03-Nov-2016 | Reverse Merger | Drug Discovery |
Biodel Exits (1)
Biodel’s most recent exit was on 03-Nov-2016 from Albireo. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Albireo | 03-Nov-2016 | Completed |
|
Biodel FAQs
-
When was Biodel founded?
Biodel was founded in 2003.
-
Where is Biodel headquartered?
Biodel is headquartered in Danbury, CT.
-
What is the size of Biodel?
Biodel has 39 total employees.
-
What industry is Biodel in?
Biodel’s primary industry is Drug Discovery.
-
Is Biodel a private or public company?
Biodel is a Private company.
-
What is Biodel’s current revenue?
The current revenue for Biodel is .
-
How much funding has Biodel raised over time?
Biodel has raised $223M.
-
Who are Biodel’s investors?
Great Point Partners, Lancet Capital, Lincoln Park Capital, NMT Capital, and OrbiMed are 5 of 8 investors who have invested in Biodel.
-
Who are Biodel’s competitors?
4D pharma, Vedanta Biosciences, Voyager Therapeutics, WaVe Life Sciences, and Maze Therapeutics are some of the 63 competitors of Biodel.
-
Who acquired Biodel?
Biodel was acquired by Albireo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process